G. Yves Laflamme MD FRCS(c)1, Jonah Hébert‐Davies MD FRCS(c),c2 and Dominique M. Rouleau MD MSc FRCS(c)1 1Sacré‐Coeur Hospital, University of Montreal, Montreal, QC, Canada 2Harborview Medical Center, University of Washington, Seattle, WA, USA Temporary stabilization is crucial for the survival of patients with a life‐threatening pelvic ring injury. Until recently, urgent application of external fixation was widely used. Experimental studies have shown that the retroperitoneal compartment is an open space1 and that the tamponade effect of the pelvis is minimal. According to the ATLS (acute trauma life support )guidelines, a PB should be applied before mechanical fixation. During the immediate resuscitative period, the trauma team can quickly wrap a simple bedsheet around her pelvis and thighs before the orthopedic surgeon arrives. Blood pressure and heart rate improve dramatically 10 minutes post application. Two systematic reviews have been published on the effectiveness of circumferential pelvic compression devices for unstable pelvic fractures.2,3 The most recent, published in 2016, found sufficient evidence to suggest that external compression mechanically reduces disrupted pelvic rings. Although the short‐term physiological effectiveness of PB has been shown, the long‐term outcome regarding mortality remains unclear.2 Similar conclusions were reported in the other systematic review that included 17 articles with only one level III study. Authors concluded that, although PB appears to be effective, there was a lack of prospective data.3 A trauma registry analysis by Croce et al. compared external fixators to PB in a cohort of 186 patients and found a lower mortality rate in the PB group but the results were not statistically significant (p = 0.011).4 However, blood transfusions at 24 (4.9 vs 17.1 units) and 48 hours (6 vs 18.6 units) were statistically lower for the PB group than for the external fixation group (p <0.0001). In a retrospective study of 585 patients treated with and without PB upon arrival at a trauma center, Fu et al. reported a significant reduction in transfusion rates (398 ± 417 ml vs 1954 ± 249 ml, p = 0.006) and a shorter intensive care length of stay (6.6 vs 11.8 days, p = 0.02).5 Another retrospective analysis on 118 patients treated with PB upon patient arrival and continued for 24 to 72 hours, compared them with historical controls in the preceding year (n = 119).6 PB had no effect on mortality (23% vs 23%, p = 0.92), need for pelvic AE (11% vs 15%, p = 0.35), or 24‐hour transfusions (5.2 ± 10.0 vs 4.6 ± 9.0 U, p = 0.64). In the hemodynamic unstable pelvic fracture, evidence suggests (overall quality: low): Reducing blood loss is crucial for the survival of patients with a pelvic injury and hemodynamic instability. In conjunction with bone stabilization, there are two possible methods of hemorrhage control: PPP and AE. Guidelines currently provide contradictory recommendations over which treatment should be preferred. After temporary hemodynamic stabilization, the patient undergoes a secondary drop in blood pressure to 85/50. Repeated secondary survey does not reveal any other source of bleeding. The general surgeon wants to perform PPP while the orthopedic team would prefer beginning with AE. Following a publication from the American Association for Surgery of Trauma, embolization (10%) is used much more frequently than PPP (5%) to control bleeding in unstable pelvic injuries in the USA,7 whereas PPP is more frequently reported in European literature. The most common complication for PPP is infection in 15% of cases. The unique complications reported for embolization are ischemia of the gluteus muscles and those related to IV contrast.8
91
Pelvic Fractures
Clinical scenario
Top three questions
Question 1: During the initial management of patients with suspected pelvic bleeding, does the application of an invasive external fixator provide superior pelvic hemorrhage control when compared to a noninvasive external pelvic binder (PB)?
Rationale
Clinical comment
Available literature and quality of the evidence
Findings
Resolution of clinical scenario
Question 2: For patients with ongoing pelvic bleeding after resuscitation, does giving priority to pre‐peritoneal pelvic packing (PPP), before angioembolization (AE), reduce mortality?
Rationale
Clinical comment
Available literature and quality of the evidence
Findings